• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤疾病:用于治疗皮肤紊乱的新药。

Skin conditions: new drugs for managing skin disorders.

作者信息

Nguyen Tam, Zuniga Ramiro

机构信息

San Joaquin General Hospital, French Camp, CA 95231,USA.

出版信息

FP Essent. 2013 Apr;407:11-6.

PMID:23600334
Abstract

New drugs are available for managing several common skin disorders. For psoriasis, topical corticosteroids remain the first-line therapy, but topical vitamin D3 analogs, such as calcipotriene, now have a role. They are as effective as medium-potency topical steroids but without steroid side effects, though they can induce hypercalcemia if the dose exceeds 100 g/week. For more severe cases, methotrexate has been widely used, but other drugs now also are prescribed. They include calcineurin inhibitors, such as cyclosporine, and more recently, biologic agents, such as tumor necrosis factor inhibitors. For children and pregnant women, in whom the previously discussed drugs are not appropriate, narrowband UV-B light often is the first-line treatment. For eczema, patients requiring steroid-sparing topical drugs can be treated with calcineurin inhibitors (ie, pimecrolimus or tacrolimus); between the 2, tacrolimus is the first choice for adults and children older than 2 years. When systemic management is needed, oral calcineurin inhibitors (eg, cyclosporine) are appropriate, though oral steroids often are needed for severe cases. The need for systemic management can sometimes be delayed with use of diluted bleach baths. For acne vulgaris, standard treatments with topical benzoyl peroxide and topical or systemic antibiotics are used widely, as are oral contraceptives, but oral isotretinoin is the most effective treatment.

摘要

有多种新药可用于治疗几种常见的皮肤病。对于银屑病,外用糖皮质激素仍是一线治疗药物,但外用维生素D3类似物,如卡泊三醇,现在也发挥着作用。它们的疗效与中效外用类固醇相当,但无类固醇副作用,不过如果剂量超过100μg/周,可能会诱发高钙血症。对于更严重的病例,甲氨蝶呤已被广泛使用,但现在也会开其他药物。这些药物包括钙调神经磷酸酶抑制剂,如环孢素,以及最近的生物制剂,如肿瘤坏死因子抑制剂。对于儿童和孕妇,上述药物不合适,窄谱UV - B光通常是一线治疗方法。对于湿疹,需要使用不含类固醇外用药物的患者可用钙调神经磷酸酶抑制剂(即吡美莫司或他克莫司)治疗;两者相比,他克莫司是成人和2岁以上儿童的首选。当需要全身治疗时,口服钙调神经磷酸酶抑制剂(如环孢素)是合适的,不过严重病例通常需要口服类固醇。有时使用稀释的漂白浴可推迟全身治疗的需求。对于寻常痤疮,外用过氧化苯甲酰以及外用或口服抗生素的标准治疗方法被广泛使用,口服避孕药也常用,但口服异维A酸是最有效的治疗方法。

相似文献

1
Skin conditions: new drugs for managing skin disorders.皮肤疾病:用于治疗皮肤紊乱的新药。
FP Essent. 2013 Apr;407:11-6.
2
Innovative use of topical calcineurin inhibitors.局部钙调磷酸酶抑制剂的创新应用。
Dermatol Clin. 2010 Jul;28(3):535-45. doi: 10.1016/j.det.2010.03.008.
3
New and emerging treatments in dermatology: acne.皮肤科的新型及新兴治疗方法:痤疮
Dermatol Ther. 2008 Mar-Apr;21(2):86-95. doi: 10.1111/j.1529-8019.2008.00175.x.
4
Potential new indications of topical calcineurin inhibitors.局部钙调神经磷酸酶抑制剂的潜在新适应症。
Dermatology. 2007;215 Suppl 1:45-54. doi: 10.1159/000102119. Epub 2007 Dec 18.
5
New and existing therapeutic options for hand eczema.手部湿疹的新治疗方法与现有治疗选择。
Skin Therapy Lett. 2009 Mar;14(3):1-5.
6
Topical management of psoriasis - corticosteroids and sparing corticosteroid therapy.银屑病的局部治疗——皮质类固醇及皮质类固醇节约疗法
Acta Dermatovenerol Croat. 2006;14(3):188-96.
7
[Management of acne in adolescents].青少年痤疮的管理
Arch Pediatr. 2007 Sep;14(9):1152-6. doi: 10.1016/j.arcped.2007.05.011. Epub 2007 Jul 10.
8
[Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid].外用过氧化苯甲酰、抗生素和壬二酸治疗痤疮
J Dtsch Dermatol Ges. 2006 Apr;4(4):293-300. doi: 10.1111/j.1610-0387.2006.05931.x.
9
[Diagnostic, prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force of the National Specialists on Dermatology, Venereology and Allergology].[特应性皮炎患者的诊断、预防和治疗指南。国家皮肤科、性病学和过敏学专家工作组立场文件]
Pol Merkur Lekarski. 2004;17 Suppl 3:3-15.
10
Corticosteroids: options in the era of steroid-sparing therapy.皮质类固醇:类固醇节省疗法时代的选择
J Am Acad Dermatol. 2005 Jul;53(1 Suppl 1):S50-8. doi: 10.1016/j.jaad.2005.04.030.

引用本文的文献

1
Study for Evaluation of Hydrogels after the Incorporation of Liposomes Embedded with Caffeic Acid.包埋有咖啡酸的脂质体掺入后水凝胶的评估研究。
Pharmaceuticals (Basel). 2022 Jan 31;15(2):175. doi: 10.3390/ph15020175.
2
Lipid-Based Nanosystems as a Tool to Overcome Skin Barrier.基于脂质的纳米系统作为克服皮肤屏障的工具。
Int J Mol Sci. 2021 Aug 2;22(15):8319. doi: 10.3390/ijms22158319.